Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Savicell logo — THE IMMUNOBIOPSY™ COMPANY – BECAUSE EARLY DETECTION IS LIFE™

Savicell

THE IMMUNOBIOPSY™ COMPANY – BECAUSE EARLY DETECTION IS LIFE™

Founded 2007 Israel Israel 7 employees Biotechnology, Health Care

General Information

Company Name Savicell
Founded Year 2007
Location Israel Israel
Employees 7
Industries Biotechnology, Health Care
Social

BounceWatch is an independent company data service, not affiliated with Savicell. To contact Savicell, visit savicell.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Savicell compare?

A PDF of Savicell and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Savicell soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Savicell

Savicell is a biotechnology startup based in Israel established in 2007. The company focuses on early disease detection, particularly cancer, with its innovative Well-Shield™ platform. Savicell's liquid ImmunoBiopsy™ technology aims to identify various diseases and track treatment effectiveness, including immunotherapy, in the underserved cancer liquid biopsy market. The company's approach is based on the understanding that metabolic changes in the immune system impact immune response outcomes, allowing for disease-specific identification based on unique immune metabolic profiles. By measuring these energy changes, Savicell's Liquid ImmunoBiopsy can distinguish between and within various ailments, such as cancers, autoimmune diseases, and infectious diseases. With its groundbreaking technology and strategic focus on early disease detection, Savicell is poised to make a significant impact in the biotechnology and healthcare industries.

Business keywords: Cancer detection, Liquid biopsy, Early disease detection, Metabolomics, Immunotherapy, Medical diagnostics, Immune system analysis, Infectious disease detection

No funding data available for Savicell yet.

Savicell Alternatives & Competitors

View All Alternatives
Savicell vs
Thrive Earlier Detection
Thrive Earlier Detection

Pioneering Life-Saving Cancer Detection with Advanced Liquid Biopsy Solutions

Venture round
Biotechnology, Health Care
Savicell vs
Elypta
Elypta Sweden

Advancing cancer detection

Grant
32 employees
Biotechnology, Health Care
Savicell vs
VisionGate, Inc.
VisionGate, Inc. United States

Leading the Battle Against Lung Cancer through our Early Detection Technology

Venture round
24 employees
Biotechnology, Health Care
Also compare with: Savicell vs Adaptive Biotechnologies Corp. Adaptive Biotechnologies Corp. View all alternatives

FAQ About Savicell

THE IMMUNOBIOPSY™ COMPANY – BECAUSE EARLY DETECTION IS LIFE™
Savicell was founded in 2007.
Savicell is headquartered in Israel.
Savicell operates in Biotechnology and Health Care. Its work centres on Cancer detection, Liquid biopsy, Early disease detection and Metabolomics.
Savicell has approximately 7 employees.
Top alternatives and competitors to Savicell include Thrive Earlier Detection, Elypta, VisionGate, Inc., PrognomiQ Inc, ENDRA Life Sciences (Nasdaq: NDRA). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Savicell and Thrive Earlier Detection are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Savicell, https://bouncewatch.com/company/savicell, updated 31 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout